Chronic Kidney Disease (CKD) Drugs Market Report – Research, Industry Analysis Reports and Market Demands

Global Chronic Kidney Disease (CKD) Drugs Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Chronic Kidney Disease (CKD) Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Product
- 1.4.2 ACE inhibitors
- 1.4.3 Angiotensin-II receptor blockers
- 1.4.4 Calcium channel blockers
- 1.4.5 Beta blockers: BREVIBLOC, Bystolic
- 1.4.6 Others
1.5 Market by End User
- 1.5.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size
- 2.1.1 Global Chronic Kidney Disease (CKD) Drugs Revenue 2014-2025
- 2.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales 2014-2025
2.2 Chronic Kidney Disease (CKD) Drugs Growth Rate by Regions
- 2.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Regions
- 2.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers
- 3.1.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers
- 3.1.2 Chronic Kidney Disease (CKD) Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Chronic Kidney Disease (CKD) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers
- 3.2.1 Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Chronic Kidney Disease (CKD) Drugs Price by Manufacturers
3.4 Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Chronic Kidney Disease (CKD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Product
4.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Product
4.3 Chronic Kidney Disease (CKD) Drugs Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Chronic Kidney Disease (CKD) Drugs Breakdown Data by End User

6 North America

6.1 North America Chronic Kidney Disease (CKD) Drugs by Countries
- 6.1.1 North America Chronic Kidney Disease (CKD) Drugs Sales by Countries
- 6.1.2 North America Chronic Kidney Disease (CKD) Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Chronic Kidney Disease (CKD) Drugs by Product
6.3 North America Chronic Kidney Disease (CKD) Drugs by End User

7 Europe

7.1 Europe Chronic Kidney Disease (CKD) Drugs by Countries
- 7.1.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Countries
- 7.1.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Chronic Kidney Disease (CKD) Drugs by Product
7.3 Europe Chronic Kidney Disease (CKD) Drugs by End User

8 Asia Pacific

8.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs by Countries
- 8.1.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Countries
- 8.1.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs by Product
8.3 Asia Pacific Chronic Kidney Disease (CKD) Drugs by End User

9 Central & South America

9.1 Central & South America Chronic Kidney Disease (CKD) Drugs by Countries
- 9.1.1 Central & South America Chronic Kidney Disease (CKD) Drugs Sales by Countries
- 9.1.2 Central & South America Chronic Kidney Disease (CKD) Drugs Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Chronic Kidney Disease (CKD) Drugs by Product
9.3 Central & South America Chronic Kidney Disease (CKD) Drugs by End User

10 Middle East and Africa

10.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by Countries
- 10.1.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Countries
- 10.1.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by Product
10.3 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by End User

11 Company Profiles

12 Future Forecast

12.1 Chronic Kidney Disease (CKD) Drugs Market Forecast by Regions
- 12.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Regions 2019-2025
12.2 Chronic Kidney Disease (CKD) Drugs Market Forecast by Product
- 12.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Product 2019-2025
12.3 Chronic Kidney Disease (CKD) Drugs Market Forecast by End User
12.4 North America Chronic Kidney Disease (CKD) Drugs Forecast
12.5 Europe Chronic Kidney Disease (CKD) Drugs Forecast
12.6 Asia Pacific Chronic Kidney Disease (CKD) Drugs Forecast
12.7 Central & South America Chronic Kidney Disease (CKD) Drugs Forecast
12.8 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Chronic Kidney Disease (CKD) Drugs Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.
Calcium channel blockers surfaced as the key drug class
The hospitals segment, which is the current market leader, is expected to continue its dominance in this market over the next few years.
The global Chronic Kidney Disease (CKD) Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Chronic Kidney Disease (CKD) Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Chronic Kidney Disease (CKD) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chronic Kidney Disease (CKD) Drugs in these regions.
This research report categorizes the global Chronic Kidney Disease (CKD) Drugs market by top players/brands, region, type and end user. This report also studies the global Chronic Kidney Disease (CKD) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer, Inc.
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical Co., Ltd.

Market size by Product
ACE inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers: BREVIBLOC, Bystolic
Others
Market size by End User
Hospitals
Specialty Clinics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Chronic Kidney Disease (CKD) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Chronic Kidney Disease (CKD) Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Chronic Kidney Disease (CKD) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Chronic Kidney Disease (CKD) Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Chronic Kidney Disease (CKD) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chronic Kidney Disease (CKD) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.